# Local drug activation by bioorthogonal chemistry: an implanted hydrogel and a systemic doxorubicin prodrug in a sarcoma xenograft

Source: https://onco.cc/key-papers/paper-mejia-oneto-local-hydrogel-systemic-prodrug-sarcoma-acs-cent-sci-2016/  
OnCo record `paper-mejia-oneto-local-hydrogel-systemic-prodrug-sarcoma-acs-cent-sci-2016` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The first demonstration, in mice, of the idea that became SQ3370: a material placed beside a tumour switches on a doxorubicin prodrug given into the blood.

## Summary

Shasqi's founder and collaborators present an approach they name local drug activation: bioorthogonal chemistry is used to concentrate and activate a systemic small molecule at a chosen place. The method does not depend on cellular or environmental markers, only on a biomaterial implanted beforehand near the site. In mice carrying xenografts of HT1080, a soft tissue sarcoma line, a doxorubicin prodrug activated this way gave a clear therapeutic benefit over systemic therapy with minimal side effects.

## Fields

- Kind: Key paper
- Last checked: 2026-11-16
- Also known as: In Vivo Bioorthogonal Chemistry Enables Local Hydrogel and Systemic Pro-Drug To Treat Soft Tissue Sarcoma
- Journal: ACS Central Science
- Year: 2016
- DOI: 10.1021/acscentsci.6b00150
- Authors: Mejia Oneto JM, Khan I, Seebald L, Royzen M
- Findings: In mice with HT1080 soft tissue sarcoma xenografts, a doxorubicin prodrug activated at a pre-implanted biomaterial outperformed systemic therapy with minimal side effects; the abstract gives no figures.
- What it means: This is the origin of the approach, published four years before the first patient was treated.
- Caveats: One xenograft model in mice; the abstract states no numbers.; Funded by Shasqi.

## Sources

- ACS Cent Sci 2016: https://doi.org/10.1021/acscentsci.6b00150
- PubMed: https://pubmed.ncbi.nlm.nih.gov/27504494/
- Europe PMC (free full text): https://europepmc.org/article/MED/27504494

## Connected records

- technologies: [Click-activated prodrugs (bioorthogonal drug activation in the body)](https://onco.cc/technologies/click-activated-prodrugs/)
- companies: [Shasqi](https://onco.cc/companies/shasqi/)
- drugs: [SQ3370](https://onco.cc/drugs/sq3370/)

---
JSON: https://onco.cc/api/v1/entities/paper-mejia-oneto-local-hydrogel-systemic-prodrug-sarcoma-acs-cent-sci-2016.json